Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Endocrinology and Metabolism|January 12, 2016
Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study GroupRachel S van Leeuwaarde, Bernadette P M van Nesselrooij, Ad R Hermus, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study GroupRachel S van Leeuwaarde, Koen M Dreijerink, Margreet G Ausems, et al.
BMC Medicine|November 16, 2016
MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patientsJoanne M de Laat, Rob B van der Luijt, Carolina R C Pieterman, et al.
The American Journal of Surgical Pathology|May 18, 2023
Diagnostic Utility of Menin Immunohistochemistry in Patients With Multiple Endocrine Neoplasia Type 1 SyndromeAnna Vera D Verschuur, Aranxa S M Kok, Folkert H M Morsink, et al.
Cancers|October 23, 2021
Opposite Incidence Trends for Differentiated and Medullary Thyroid Cancer in Young Dutch Patients over a 30-Year Time SpanChantal A Lebbink, Medard F M van den Broek, Annemiek B G Kwast, et al.
Cancers|June 24, 2022
Correction: Lebbink et al. Opposite Incidence Trends for Differentiated and Medullary Thyroid Cancer in Young Dutch Patients over a 30-Year Time Span. <i>Cancers</i> 2021, <i>13</i>, 5104Chantal A Lebbink, Medard F M van den Broek, Annemiek B G Kwast, et al.
Endocrine Pathology|September 27, 2024
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres)Paola Mattiolo, Michele Bevere, Andrea Mafficini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 12, 2012
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumorsRoeland F de Wilde, Christopher M Heaphy, Anirban Maitra, et al.
The Journal of Clinical Endocrinology and Metabolism|August 7, 2015
No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1Sjoerd Nell, Rachel S van Leeuwaarde, Carolina R C Pieterman, et al.
The Journal of Clinical Endocrinology and Metabolism|October 18, 2017
CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary HyperparathyroidismKarin van der Tuin, Carli M J Tops, Muriel A Adank, et al.
Pageof 14